Buprenorphine , a partial agonist available in formulations such as Suboxone (combined with naloxone), Sublocade, and Brixadi, presents a lower risk of overdose and has become a mainstay of outpatient care
[DOI] [PubMed] [Google Scholar] 137.Wang E., Mathai D.S., Gukasyan N., Nayak S., Garcia-Romeu A
For an increasing number of women and men, weight loss injections such as semaglutide (Ozempic or Wegovy) and tirzepatide (Mounjaro or Zepbound) are gaining popularity for their ability to help patients achieve significant results
When nerves become damaged due to conditions like neuropathy, injury, or chronic inflammation, it can lead to debilitating symptoms that affect the quality of life
Starting July 1, 2025, Zepbound will be removed from their standard formularies